Ratios Uncovered: Breaking Down Novavax, Inc. (NVAX)’s Trailing Twelve Months Metrics

Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Novavax, Inc. (NASDAQ: NVAX) closed at $14.00 in the last session, down -0.43% from day before closing price of $14.06. In other words, the price has decreased by -$0.43 from its previous closing price. On the day, 23.16 million shares were traded. NVAX stock price reached its highest trading level at $14.425 during the session, while it also had its lowest trading level at $13.59.

Ratios:

We take a closer look at NVAX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.88 and its Current Ratio is at 0.90.

On May 10, 2024, BofA Securities Upgraded its rating to Neutral which previously was Underperform and also upped its target price recommendation from $4 to $12.

B. Riley Securities Upgraded its Neutral to Buy on August 09, 2023, while the target price for the stock was maintained at $15.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 18 ’24 when YOUNG JAMES F sold 7,500 shares for $13.72 per share. The transaction valued at 102,881 led to the insider holds 69,260 shares of the business.

Dubovsky Filip sold 13,904 shares of NVAX for $201,164 on Jun 17 ’24. The President, R&D now owns 66,613 shares after completing the transaction at $14.47 per share. On May 14 ’24, another insider, Dubovsky Filip, who serves as the President, R&D of the company, sold 47,312 shares for $13.90 each. As a result, the insider received 657,637 and left with 38,953 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVAX now has a Market Capitalization of 2062172032 and an Enterprise Value of 2066117760. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.97. Its current Enterprise Value per Revenue stands at 2.073 whereas that against EBITDA is -6.189.

Stock Price History:

Over the past 52 weeks, NVAX has reached a high of $23.86, while it has fallen to a 52-week low of $3.53. The 50-Day Moving Average of the stock is 34.17%, while the 200-Day Moving Average is calculated to be 104.46%.

Shares Statistics:

According to the various share statistics, NVAX traded on average about 15.14M shares per day over the past 3-months and 15012970 shares per day over the past 10 days. A total of 139.51M shares are outstanding, with a floating share count of 133.34M. Insiders hold about 5.03% of the company’s shares, while institutions hold 56.88% stake in the company. Shares short for NVAX as of 1715731200 were 45291396 with a Short Ratio of 2.52, compared to 1713139200 on 43769652. Therefore, it implies a Short% of Shares Outstanding of 45291396 and a Short% of Float of 39.200002.

Most Popular